Inside Precision Medicine: Immunotherapy boosts head & neck cancer treatment
Inside Precision Medicine recently featured a clinical trial led by the University of Cincinnati's Trisha Wise-Draper, MD.
Wise-Draper, associate professor of medicine in the Division of Hematology/Oncology in UC’s College of Medicine, Head and Neck Center of Excellence co-leader, medical director of the University of Cincinnati Cancer Center Clinical Trials Office and Lab and a UC Health physician, recently published research showing that adding immunotherapy drug pembrolizumab to the standard of care for head and neck cancer patients increased survival rates for intermediate risk patients.
Wise-Draper told Inside Precision Medicine the "high pathological response rate just after 1 dose of treatment and the survival benefit associated" was a surprising result of the study. In more than 50% of the patients, the drug caused the tumor to die before surgical resection—a much higher response than had been shown in previous studies of recurrent or metastatic head and neck cancer. Within this group, 100% of the patients were disease-free at one year.
“It was a really strong predictor of patients who are going to do well on this treatment,” Wise-Draper said. “Hopefully that is going to help us design trials to better understand who is going to respond and who is not.”
Read the Inside Precision Medicine story.
Wise-Draper's research was also featured in a Pharmacy Times article. Read the Pharmacy Times article.
Featured photo at top courtesy of UC Health.
Related Stories
UC joins novel bipolar research and clinical care network
March 12, 2025
The University of Cincinnati is one of four new national institutions to receive $2.3 million each to join the Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²) Integrated Network, a collaborative research and clinical care model with a mission to improve care, interventions and outcomes for people living with bipolar disorder.
Biomedical engineer studying blunt and blast brain injuries
March 11, 2025
Olga Liaudanskaya, assistant professor of biomedical engineering at the University of Cincinnati, always dreamed of being a scientist. After finishing her graduate degree in materials science and engineering in Italy, she came to the United States for her postdoctoral program, where her research focused on the brain. This led her to a faculty position at UC’s College of Engineering and Applied Science. Recently, she was awarded funding from the Department of Defense for a project on the molecular mechanisms triggered by blunt and blast brain injuries.
REVIEW: CCM's 'A Midsummer Night's Dream' an 'exuberant triumph
March 10, 2025
The Cincinnati Business Courier praises UC College-Conservatory of Music's production of A Midsummer Night's Dream. Presented as part of the Opera Series on March 6-9, the production was directed by Robin Guarino and conducted by alumni guest artist William Langley.